Paxil and risk of breast cancer

image

Anti-depressant Paxil and risk of breast cancer…
By Courtney Blair

Depression is a serious illness that affects a lot of people and it’s not something we’d ever want a love one to go through. Likewise, cancer can have devastating effects on people and more so those who have lost a family member to it.

So what do you do when you’re told the anti-depressant medication you’ve been placed on can cause breast cancer? While Paxil may claim save a person’s life in one way, it could utterly take it away in another.

This seems to be exactly what’s happening with Paxil, as a trial was done to determine if anti-depressants and breast cancer were directly linked together. In that study, popular anti-depressant Paxil was one of the medications that came up as having the ability to promote the growth of cancerous breast tissue in women.

This is crucial information because many of the women who’re currently being treated for breast cancer were the same people who were also being treated for symptoms and signs of having depression. You’ll notice that last year around the summer time, the FDA approved the same low doses of paroxetine, under a different name in order to help treat women who were suffering from symptoms of menopause.

Further research went on to show that the very same drug that was being used to help treat women who’re suffering from depression or using Paxil as a non-hormonal treatment for menopause, had bodies unable to process the medication.

Paxil was shown to prevent the liver’s enzymes from processing the medical side-effects from Paxil as well as another popular drug used to treat infertility and breast cancer called Tamoxifen. We’re finding that Paxil is interfering with the way the body is making estrogen as well as how the body handles the amounts of estrogen it receives which makes it extremely sensitive.

Now when you’re combining that sensitivity with another medicine that is compromising natural hormonal balance, we’re coming up with multiple cases all over the world where women are developing breast cancer.

These studies have included numerous other anti-depressants and it was Paxil alone, that stood out more than any other anti-depressant out there. That’s a scary thing to know that people are not only having to worry about the other side effects that are associated with medications, but now women are having to worry if they’re going to develop breast cancer.

For patients who’re taking Tamoxifen, we’re giving them a medication to treat cancer and basically it’s a death sentence. The medication prevents the body from using the medication for its intended purpose which has significantly increased the likelihood of them dying.

The same goes for women who’ve been given Tamoxifen to be treated for infertility. They’re already having issues conceiving, and then we’re throwing in the fact that it’s compromising their bodies ability to fight off cancerous tumors in the event that they get them.

Unfortunately, you still won’t see the FDA taking a stance against either of these medications or pulling them from the shelves.

Consider a nutritive alternative to treating depression!

http://blogs.psychcentral.com/nlp/2015/12/fast-recovery-from-depression-with-magnesium/

 

References:

http://articles.latimes.com/2014/feb/18/science/la-sci-sn-antidepressant-paxil-breast-cancer-20140218

Mike Bundrant
Watch the free video The AHA! Process: An End to Self-Sabotage and discover the lost keys to personal transformation and emotional well-being that have been suppressed by mainstream mental health for decades.

The information in this video has been called the missing link in mental health and personal development. In a world full of shallow, quick-fix techniques, second rate psychology and pharmaceutical takeovers, real solutions have become nearly impossible to find. This presentation will turn your world upside down.

Mike Bundrant is co-founder of the iNLP Center and host of Mental Health Exposed, a Natural News Radio program.

Follow Mike on Facebook for daily personal development tips.